These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15509424)

  • 1. Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti.
    Mathieu E; Lammie PJ; Radday J; Beach MJ; Streit T; Wendt J; Addiss DG
    Ann Trop Med Parasitol; 2004 Oct; 98(7):703-14. PubMed ID: 15509424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
    Krentel A; Fischer P; Manoempil P; Supali T; Servais G; Rückert P
    Trop Med Int Health; 2006 Nov; 11(11):1731-40. PubMed ID: 17054754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of compliance in mass drug administration for the treatment and prevention of lymphatic filariasis in Leogane, Haiti.
    Talbot JT; Viall A; Direny A; de Rochars MB; Addiss D; Streit T; Mathieu E; Lammie PJ
    Am J Trop Med Hyg; 2008 Feb; 78(2):283-8. PubMed ID: 18256430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage.
    Ramaiah KD; Vijay Kumar KN; Hosein E; Krishnamoorthy P; Augustin DJ; Snehalatha KS; Nanda B; Das PK
    Ann Trop Med Parasitol; 2006 Jun; 100(4):345-61. PubMed ID: 16762115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.
    de Rochars MB; Kanjilal S; Direny AN; Radday J; Lafontant JG; Mathieu E; Rheingans RD; Haddix AC; Streit TG; Beach MJ; Addiss DG; Lammie PJ
    Am J Trop Med Hyg; 2005 Nov; 73(5):888-94. PubMed ID: 16282299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
    Njomo DW; Kimani BW; Kibe LW; Okoyo C; Omondi WP; Sultani HM
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0009012. PubMed ID: 33370300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
    Bockarie MJ; Alexander ND; Hyun P; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
    Lancet; 1998 Jan; 351(9097):162-8. PubMed ID: 9449870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation in three consecutive mass drug administrations in Leogane, Haiti.
    Mathieu E; Direny AN; de Rochars MB; Streit TG; Addiss DG; Lammie PJ
    Trop Med Int Health; 2006 Jun; 11(6):862-8. PubMed ID: 16772008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008.
    Cantey PT; Rao G; Rout J; Fox LM
    Trop Med Int Health; 2010 Feb; 15(2):224-31. PubMed ID: 20002615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis.
    Ramaiah KD; Vijay Kumar KN; Ravi R; Das PK
    Ann Trop Med Parasitol; 2005 Apr; 99(3):243-52. PubMed ID: 15829134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration.
    Cabral S; Bonfim C; Oliveira R; Oliveira P; Guimarães T; Brandão E; Aguiar-Santos AM; Medeiros Z
    Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e23. PubMed ID: 28443941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.
    Njomo DW; Amuyunzu-Nyamongo M; Magambo JK; Njenga SM
    PLoS One; 2012; 7(11):e48395. PubMed ID: 23185256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.
    Cantey PT; Rout J; Rao G; Williamson J; Fox LM
    PLoS Negl Trop Dis; 2010 Jun; 4(6):e728. PubMed ID: 20628595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala.
    Aswathy S; Beteena K; Leelamoni K
    Ann Trop Med Parasitol; 2009 Oct; 103(7):617-24. PubMed ID: 19825283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of malaria and lymphatic filariasis in bateyes of the Dominican Republic.
    Keys HM; Noland GS; De Rochars MB; Blount S; Gonzales M
    Infect Dis Poverty; 2019 May; 8(1):39. PubMed ID: 31130142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India.
    Rath K; Nath N; Shaloumy M; Swain BK; Suchismita M; Babu BV
    Trop Biomed; 2006 Dec; 23(2):156-62. PubMed ID: 17322817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti.
    Boyd A; Won KY; McClintock SK; Donovan CV; Laney SJ; Williams SA; Pilotte N; Streit TG; Beau de Rochars MV; Lammie PJ
    PLoS Negl Trop Dis; 2010 Mar; 4(3):e640. PubMed ID: 20351776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
    Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
    J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
    [No Abstract]   [Full Text] [Related]  

  • 19. Mass drug administration for the elimination of lymphatic filariasis--Port-au-Prince, Haiti, 2011-2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jun; 62(23):466-8. PubMed ID: 23760187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study.
    Agarwal A; Maharshi V
    Indian J Public Health; 2024 Apr; 68(2):194-200. PubMed ID: 38953805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.